Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Pacific Edge Limited

PFGTF
Current price
0.064 USD 0 USD (0.00%)
Last closed 0.064 USD
ISIN unknown
Sector Healthcare
Industry Diagnostics & Research
Exchange PINK
Capitalization 51 922 032 USD
Yield for 12 month +6.31 %
1Y
3Y
5Y
10Y
15Y
PFGTF
21.11.2021 - 28.11.2021

Pacific Edge Limited, a cancer diagnostics company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally. It operates through two segments, Commercial and Research. The company offers Cxbladder, a genomic urine biomarker test for the detection and surveillance of bladder cancer. It also develops Cxbladder Triage, a frontline diagnostic product that helps de-intensify clinical work-up for patients with haematuria who have a low probability of bladder cancer; Cxbladder Detect, which enables the risk stratification of patients with haematuria; and Cxbladder Monitor, a non-invasive surveillance alternative that reduces the burden of repeated cystoscopy in patients with a low risk of recurrence. In addition, the company is developing products for bladder, gastric, colorectal, endometrial cancers, and melanoma. Pacific Edge Limited was incorporated in 2001 and is headquartered in Dunedin, New Zealand. Address: Centre for Innovation, Dunedin, New Zealand, 9016

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

Dividend Yield

Current Year

+14 752 171 USD

Last Year

+7 573 689 USD

Current Quarter

+2 080 564 USD

Last Quarter

+2 198 649 USD

Current Year

+6 967 897 USD

Last Year

+3 708 081 USD

Current Quarter

+1 045 357 USD

Last Quarter

+1 104 688 USD

Key Figures PFGTF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -32 829 000 USD
Operating Margin TTM -139.43 %
PE Ratio
Return On Assets TTM -26.86 %
PEG Ratio
Return On Equity TTM -43 %
Wall Street Target Price
Revenue TTM 25 229 000 USD
Book Value 0.067 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -2.5 %
Dividend Yield
Gross Profit TTM 11 684 000 USD
Earnings per share -0.02 USD
Diluted Eps TTM -0.02 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin -117.07 %

Dividend Analytics PFGTF

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History PFGTF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation PFGTF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 47.619
Enterprise Value Revenue 1.2768
Price Sales TTM 2.058
Enterprise Value EBITDA -5.2285
Price Book MRQ 1.4181

Financials PFGTF

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators PFGTF

For 52 weeks

0.025 USD 0.069 USD
50 Day MA 0.061 USD
Shares Short Prior Month
200 Day MA 0.059 USD
Short Ratio
Shares Short
Short Percent